Please join Amgen and Regencor co-founder, Pilar Ruiz-Lozano, for the next Founders-At-Work Speaker Series where entrepreneurs connect, share their stories and talk about science!RSVPhttps://mbcbiolabs.com/wp-content/uploads/2019/11/Ruiz-Lozano.jpg Speaker: As a member of the Faculty at Stanford School of Medicine, Dr. Ruiz-Lozano pioneered the development of tissue engineering and epicardial biology to treat heart disease.  She led the discovery of the cardiac regenerative properties of recombinant human FSTL1 and the development of delivery modalities that are now licensed by Regencor, Inc.

Please join Caribou Biosciences co-founder, Rachel Haurwitz, for the next Founders-At-Work Speaker Series where entrepreneurs connect, share their stories and talk about science! RSVPhttps://mbcbiolabs.com/wp-content/uploads/2019/11/Rachel-Haurwitz.jpg Speaker: Rachel Haurwitz is a co-founder of Caribou Biosciences and has been President and CEO since its inception. She has a research background in CRISPR-Cas biology, and is also a co-founder of Intellia Therapeutics. In 2014, she was named by Forbes Magazine to the "30 Under 30" list in Science and Healthcare, and in 2016, Fortune Magazine named her to the "40 Under 40" list of the most influential young people in business. Rachel is an inventor on several patents and patent applications covering multiple CRISPR-derived technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. Rachel earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.